Capita And Cabinet Office To Sell AXELOS To PeopleCert

Capita plc (CPI.L), on Monday, announced that Capita and Cabinet Office have agreed to sell AXELOS Ltd. to PeopleCert International Ltd. in a deal that values the joint venture at £380.0 million on a cash-free, debt-free basis, representing an 11.5x multiple on 2020 EBITDA of £33.1 million.

Upon completion, Capita would receive net cash proceeds of £172.5 million from the sale of Capita's 51% interest in AXELOS. Prior to completion, Capita would also receive a cash dividend of £11.1 million making total net cash receipts of £183.6 million.

This would provide additional liquidity to strengthen Capita's balance sheet, meet upcoming debt maturities and support the ongoing implementation of its transformation plan. As part of the PeopleCert investment in AXELOS, FTV Capital Management would become a minority shareholder in PeopleCert.

The sale of AXELOS follows a strategic review of the joint venture by Capita and Cabinet Office and comes as Capita moves into the next phase of its transformation.

As Capita holds a 51% interest in AXELOS, it is included in the Capita Group's consolidated accounts. The gross assets of AXELOS at, and the profit before tax for the year to, 31 December 2020, were £115.7 million and £24.3 million respectively.

Capita further stated that it continues to make good progress with its planned disposals, and remains on track to realise combined proceeds of at least £200 million this year, in addition to the £299 million initial payment received from the sale of ESS in February.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
CVS Health is set to recruit qualified candidates to fill 25,000 clinical and retail jobs during a one-day national career event on Friday, September 24. This will enable CVS to meet the high demand for pharmacists, pharmacy technicians, nurses, and retail store associates to support flu season, COVID-19 vaccinations and testing. Twitter, Inc. (TWTR) announced Monday that it has entered into a binding agreement to settle the consolidated class action lawsuit commenced in 2016 in the United States District Court for the Northern District of California. Under the terms of the proposed settlement, Twitter will pay $809.5 million... Drug major Pfizer has again expanded the earlier two recalls of its anti-smoking Drug Chantix (Varenicline) in the form of tablets, to now include all the lots, for the potential presence of nitrosamine impurity, N-Nitroso- varenicline, at or above the FDA interim acceptable intake limit (ADI), the U.S. Food and Drug Administration or FDA said in a statement.
Follow RTT